GeneMatrix Inc (109820) - Total Liabilities

Latest as of September 2025: ₩9.72 Billion KRW ≈ $6.59 Million USD

Based on the latest financial reports, GeneMatrix Inc (109820) has total liabilities worth ₩9.72 Billion KRW (≈ $6.59 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore GeneMatrix Inc (109820) cash flow conversion to assess how effectively this company generates cash.

GeneMatrix Inc - Total Liabilities Trend (2011–2024)

This chart illustrates how GeneMatrix Inc's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of GeneMatrix Inc to evaluate the company's liquid asset resilience ratio.

GeneMatrix Inc Competitors by Total Liabilities

The table below lists competitors of GeneMatrix Inc ranked by their total liabilities.

Company	Country	Total Liabilities
JAS Asset PCL BK:J	Thailand	฿3.18 Billion
Auris Minerals Ltd AU:AUR	Australia	AU$253.26K
Bellway PLC LSE:BWY	UK	GBX1.64 Billion
CL Educate Limited NSE:CLEDUCATE	India	Rs7.17 Billion
Shivam Autotech Limited NSE:SHIVAMAUTO	India	Rs4.75 Billion
WI Co. Ltd. KQ:073570	Korea	₩2.15 Billion
Mount Ridley Mines Ltd AU:MRD	Australia	AU$52.21K
Biocartis Group NV BR:BCART	Belgium	€166.97 Million

Liability Composition Analysis (2011–2024)

This chart breaks down GeneMatrix Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see GeneMatrix Inc market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.26	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.53	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.35	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GeneMatrix Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GeneMatrix Inc (2011–2024)

The table below shows the annual total liabilities of GeneMatrix Inc from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩9.23 Billion ≈ $6.26 Million	+12.49%
2023-12-31	₩8.21 Billion ≈ $5.56 Million	+6.34%
2022-12-31	₩7.72 Billion ≈ $5.23 Million	+7.01%
2021-12-31	₩7.21 Billion ≈ $4.89 Million	+51.02%
2020-12-31	₩4.78 Billion ≈ $3.24 Million	-63.84%
2019-12-31	₩13.21 Billion ≈ $8.95 Million	-36.15%
2018-12-31	₩20.68 Billion ≈ $14.02 Million	+209.45%
2017-12-31	₩6.68 Billion ≈ $4.53 Million	-2.43%
2016-12-31	₩6.85 Billion ≈ $4.64 Million	-36.24%
2015-12-31	₩10.74 Billion ≈ $7.28 Million	+108.13%
2014-12-31	₩5.16 Billion ≈ $3.50 Million	-25.15%
2013-12-31	₩6.90 Billion ≈ $4.67 Million	+7.29%
2012-12-31	₩6.43 Billion ≈ $4.36 Million	-6.58%
2011-12-31	₩6.88 Billion ≈ $4.66 Million	--

About GeneMatrix Inc

KQ:109820 Korea Diagnostics & Research

Market Cap

$27.26 Million

₩40.23 Billion KRW

Market Cap Rank

#24027 Global

#1738 in Korea

Share Price

₩2015.00

Change (1 day)

-2.42%

52-Week Range

₩1899.00 - ₩3345.00

All Time High

₩33900.00